{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:58:40Z","timestamp":1790337520012,"version":"4.1.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HPLS"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s40656-026-00759-w","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:02:15Z","timestamp":1790334135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Benefit assessment of anti-ageing medicines in the European Union: regulatory obstacles and pluralistic alternatives"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1022-6479","authenticated-orcid":false,"given":"Guillermo","family":"Mar\u00edn Penella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-2813","authenticated-orcid":false,"given":"Roberto","family":"L\u00f3pez-Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"S1","key":"759_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/09637486.2011.636344","volume":"63","author":"PJ Aggett","year":"2012","unstructured":"Aggett, P. J. (2012). Dose-response relationships in multifunctional food design: Assembling the evidence. International Journal of Food Sciences and Nutrition, 63(S1), 37\u201342. https:\/\/doi.org\/10.3109\/09637486.2011.636344","journal-title":"International Journal of Food Sciences and Nutrition"},{"issue":"3","key":"759_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/MPG.0b013e31816c749f","volume":"47","author":"AK Akobeng","year":"2008","unstructured":"Akobeng, A. K. (2008). Assessing the validity of clinical trials. Journal of Pediatric Gastroenterology and Nutrition, 47(3), 277\u2013282. https:\/\/doi.org\/10.1097\/MPG.0b013e31816c749f","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"759_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/JMDH.S104807","volume":"9","author":"A Althubaiti","year":"2016","unstructured":"Althubaiti, A. (2016). Information bias in health research: Definition, pitfalls, and adjustment methods. Journal of Multidisciplinary Healthcare, 9(1), 211\u2013217. https:\/\/doi.org\/10.2147\/JMDH.S104807","journal-title":"Journal of Multidisciplinary Healthcare"},{"issue":"6","key":"759_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/01622439198280","volume":"44","author":"A Andreoletti","year":"2019","unstructured":"Andreoletti, A., & Teira, D. (2019). Rules versus standards: What are the costs of epistemic norms in drug regulation? Science, Technology & Human Values, 44(6), 1093\u20131115. https:\/\/doi.org\/10.1177\/01622439198280","journal-title":"Science, Technology & Human Values"},{"issue":"1","key":"759_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11229-024-04677-x","volume":"204","author":"M Andreoletti","year":"2024","unstructured":"Andreoletti, M., & P\u00e9rez-Gonz\u00e1lez, S. (2024). The reliability of evidential pluralism in drug regulation. Synthese, 204(1), 33. https:\/\/doi.org\/10.1007\/s11229-024-04677-x","journal-title":"Synthese"},{"key":"759_CR6","doi-asserted-by":"publisher","DOI":"10.7208\/chicago\/9780226020952.001.0001","volume-title":"The longevity seekers: Science, business and the fountain of youth","author":"T Anton","year":"2013","unstructured":"Anton, T. (2013). The longevity seekers: Science, business and the fountain of youth. University of Chicago Press."},{"key":"759_CR7","unstructured":"Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses, 21 CFR, \u00a7 314.500 et seq (1992). Retrieved January 28, 2025, from https:\/\/www.ecfr.gov\/current\/title-21\/part-314\/subpart-H"},{"key":"759_CR134","doi-asserted-by":"crossref","unstructured":"Baker, G. T., & Sprott, R. L. (1988). Biomarkers of aging. Experimental Gerontology, 23(4\u20135), 223\u2013239.","DOI":"10.1016\/0531-5565(88)90025-3"},{"key":"759_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-023-00110-8","author":"SEC Bafei","year":"2023","unstructured":"Bafei, S. E. C., & Shen, C. (2023). Biomarkers selection and mathematical modelling in biological age estimation. Npj Aging. https:\/\/doi.org\/10.1038\/s41514-023-00110-8","journal-title":"Npj Aging"},{"issue":"11","key":"759_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/dom.12354","volume":"16","author":"CA Bannister","year":"2014","unstructured":"Bannister, C. A., Holden, S. E., Jenkins-Jones, S., Morgan, C. L. I., Halcox, J. P., Schernthaner, G., Mukherjee, J., & Currie, C. J. (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes, Obesity and Metabolism, 16(11), 1165\u20131173. https:\/\/doi.org\/10.1111\/dom.12354","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"759_CR10","unstructured":"Barzilai, N., & Mazin, A. (2021, June 29). Dr. Nir Barzilai: \u201cWe Can Live Healthier for Longer\u201d. Lifespan.io. Retrieved December 1, 2023, from https:\/\/www.lifespan.io\/news\/dr-nir-barzilai-we-can-live-healthier-for-longer\/"},{"issue":"8","key":"759_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10082006","volume":"10","author":"B Benham\u00fa","year":"2022","unstructured":"Benham\u00fa, B., Mart\u00edn-Fontecha, M., V\u00e1zquez-Villa, H., L\u00f3pez-Rodr\u00edguez, M. L., & Ortega-Guti\u00e9rrez, S. (2022). New trends in aging drug discovery. Biomedicines, 10(8), Article 2006. https:\/\/doi.org\/10.3390\/biomedicines10082006","journal-title":"Biomedicines"},{"issue":"9","key":"759_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejcsup.2007.09.003","volume":"5","author":"B Berns","year":"2007","unstructured":"Berns, B., D\u00e9molis, P., & Scheulen, M. E. (2007). How can biomarkers become surrogate endpoints? EJC Supplements, 5(9), 37\u201340. https:\/\/doi.org\/10.1016\/j.ejcsup.2007.09.003","journal-title":"EJC Supplements"},{"issue":"10 Suppl.","key":"759_CR13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.nut.2011.04.002","volume":"27","author":"HK Biesalski","year":"2011","unstructured":"Biesalski, H. K., Aggett, P. J., Anton, R., Bernstein, P. S., Blumberg, J., Heaney, R. P., Henry, J., Nolan, J. M., Richardson, D. P., van Ommen, B., Witkamp, R. F., Rijkers, G. T., & Z\u00f6llner, I. (2011). 26th Hohenheim consensus conference, September 11, 2010 scientific substantiation of health claims: Evidence-based nutrition. Nutrition, 27(10 Suppl.), S1\u2013S20. https:\/\/doi.org\/10.1016\/j.nut.2011.04.002","journal-title":"Nutrition"},{"issue":"4","key":"759_CR14","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/S2666-7568(21)00024-6","volume":"2","author":"E Bischof","year":"2021","unstructured":"Bischof, E., Scheibye-Knudsen, M., Siow, R., & Moskalev, A. (2021). Longevity medicine: Upskilling the physicians of tomorrow. Lancet Healthy Longevity, 2(4), e187\u2013e188. https:\/\/doi.org\/10.1016\/S2666-7568(21)00024-6","journal-title":"Lancet Healthy Longevity"},{"issue":"7253","key":"759_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"A Bito","year":"2016","unstructured":"Bito, A., Ito, T. K., Pineda, V. V., LeTexier, N. J., Huang, H. Z., Sutlief, E., Tung, H., Vizzini, N., Chen, B., Smith, K., Meza, D., Yajima, M., Beyer, R. P., Kerr, K. F., Davis, D. J., Gillespie, C. H., Snyder, J. M., Treuting, P. M., & Kaeberlein, M. (2016). Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. eLife, 5(7253), 392\u2013395 https:\/\/doi.org\/10.1038\/nature08221","journal-title":"Nature"},{"issue":"6265","key":"759_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.aab3389","volume":"350","author":"E Blackburn","year":"2015","unstructured":"Blackburn, E., Epel, E., & Lin, J. (2015). Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science, 350(6265), 1193\u20131198. https:\/\/doi.org\/10.1126\/science.aab3389","journal-title":"Science"},{"issue":"12","key":"759_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jclinepi.2004.06.003","volume":"57","author":"E Blair","year":"2004","unstructured":"Blair, E. (2004). Gold is not always good enough: The shortcomings of randomization when evaluating interventions in small heterogeneous samples. Journal of Clinical Epidemiology, 57(12), 1219\u20131222. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.06.003","journal-title":"Journal of Clinical Epidemiology"},{"key":"759_CR18","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1007\/s11357-023-01055-2","volume":"46","author":"JM Blodgett","year":"2024","unstructured":"Blodgett, J. M., P\u00e9rez-Zepeda, M. U., Godin, J., Kehler, D. S., Andrew, M. K., Kirkland, S., Rockwood, K., & Theou, O. (2024). Prognostic accuracy of 70 individual frailty biomarkers in predicting mortality in the Canadian Longitudinal Study on Aging. GeroScience, 46, 3061\u20133069. https:\/\/doi.org\/10.1007\/s11357-023-01055-2","journal-title":"GeroScience"},{"issue":"8","key":"759_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1753-4887.2010.00307.x","volume":"68","author":"J Blumberg","year":"2010","unstructured":"Blumberg, J., Heaney, R. P., Huncharek, M., Scholl, T., Stampfer, M., Vieth, R., Weaver, C. M., & Zeisel, S. H. (2010). Evidence-based criteria in the nutritional context. Nutrition Reviews, 68(8), 478\u2013484. https:\/\/doi.org\/10.1111\/j.1753-4887.2010.00307.x","journal-title":"Nutrition Reviews"},{"key":"759_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/acprof:oso\/9780199574131.003.0003","volume-title":"Causality in the sciences","author":"A Broadbent","year":"2011","unstructured":"Broadbent, A. (2011). Inferring causation in epidemiology: Mechanisms, black boxes, and contrasts. In P. M. Illari, F. Russo, & J. Williamson (Eds.), Causality in the sciences (pp. 45\u201369). Oxford University Press. https:\/\/doi.org\/10.1093\/acprof:oso\/9780199574131.003.0003"},{"issue":"2","key":"759_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00002512-199813020-00001","volume":"13","author":"D Callahan","year":"1998","unstructured":"Callahan, D., & Topinkova, E. (1998). Is aging a preventable or curable disease? Drugs & Aging, 13(2), 93\u201397. https:\/\/doi.org\/10.2165\/00002512-199813020-00001","journal-title":"Drugs & Aging"},{"issue":"1","key":"759_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11017-010-9166-5","volume":"32","author":"R Campaner","year":"2011","unstructured":"Campaner, R. (2011). Understanding mechanisms in the health sciences. Theoretical Medicine and Bioethics, 32(1), 5\u201317. https:\/\/doi.org\/10.1007\/s11017-010-9166-5","journal-title":"Theoretical Medicine and Bioethics"},{"issue":"1","key":"759_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02698595.2012.653113","volume":"26","author":"R Campaner","year":"2012","unstructured":"Campaner, R., & Galavotti, M. C. (2012). Evidence and the assessment of causal relations in the health sciences. International Studies in the Philosophy of Science, 26(1), 27\u201345. https:\/\/doi.org\/10.1080\/02698595.2012.653113","journal-title":"International Studies in the Philosophy of Science"},{"issue":"4","key":"759_CR24","doi-asserted-by":"publisher","first-page":"970","DOI":"10.14336\/AD.2021.1213","volume":"13","author":"FF Cheng","year":"2022","unstructured":"Cheng, F. F., Liu, Y. L., Du, J., & Lin, J. T. (2022). Metformin\u2019s mechanisms in attenuating hallmarks of aging and age-related disease. Aging and Disease, 13(4), 970\u2013986. https:\/\/doi.org\/10.14336\/AD.2021.1213","journal-title":"Aging and Disease"},{"issue":"6","key":"759_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ypmed.2012.10.020","volume":"57","author":"B Clarke","year":"2013","unstructured":"Clarke, B., Gillies, D., Illari, P., Russo, F., & Williamson, J. (2013). The evidence that evidence-based medicine omits. Preventive Medicine, 57(6), 745\u2013747. https:\/\/doi.org\/10.1016\/j.ypmed.2012.10.020","journal-title":"Preventive Medicine"},{"issue":"2","key":"759_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11245-013-9220-9","volume":"33","author":"B Clarke","year":"2014","unstructured":"Clarke, B., Gillies, D., Illari, P., Russo, F., & Williamson, J. (2014). Mechanisms and the evidence hierarchy. Topoi, 33(2), 339\u2013360. https:\/\/doi.org\/10.1007\/s11245-013-9220-9","journal-title":"Topoi"},{"issue":"4","key":"759_CR27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.shpsc.2012.05.004","volume":"43","author":"F Claveau","year":"2012","unstructured":"Claveau, F. (2012). The Russo-Williamson theses in the social sciences: Causal inference drawing on two types of evidence. Studies in History and Philosophy of Biological and Biomedical Sciences, 43(4), 806\u2013813. https:\/\/doi.org\/10.1016\/j.shpsc.2012.05.004","journal-title":"Studies in History and Philosophy of Biological and Biomedical Sciences"},{"key":"759_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195074369.001.0001","volume-title":"Regulating toxic substances: A philosophy of science and the law","author":"CF Cranor","year":"1993","unstructured":"Cranor, C. F. (1993). Regulating toxic substances: A philosophy of science and the law. Oxford University Press."},{"issue":"6","key":"759_CR32","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1007\/s11357-022-00671-8","volume":"44","author":"SR Cummings","year":"2022","unstructured":"Cummings, S. R., & Kritchevsky, S. B. (2022). Endpoints for geroscience clinical trials: Health outcomes, biomarkers, and biological age. GeroScience, 44(6), 2925\u20132931. https:\/\/doi.org\/10.1007\/s11357-022-00671-8","journal-title":"GeroScience"},{"issue":"11","key":"759_CR33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tibtech.2017.07.004","volume":"35","author":"JP De Magalh\u00e3es","year":"2017","unstructured":"De Magalh\u00e3es, J. P., Stevens, M., & Thornton, D. (2017). The business of anti-aging science. Trends in Biotechnology, 35(11), 1062\u20131073. https:\/\/doi.org\/10.1016\/j.tibtech.2017.07.004","journal-title":"Trends in Biotechnology"},{"issue":"4","key":"759_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/392855","volume":"67","author":"HE Douglas","year":"2000","unstructured":"Douglas, H. E. (2000). Inductive risk and values in science. Philosophy of Science, 67(4), 559\u2013579. https:\/\/doi.org\/10.1086\/392855","journal-title":"Philosophy of Science"},{"key":"759_CR35","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctt6wrc78","volume-title":"Science, policy, and the value-free ideal","author":"HE Douglas","year":"2009","unstructured":"Douglas, H. E. (2009). Science, policy, and the value-free ideal. University of Pittsburgh Press."},{"issue":"3","key":"759_CR36","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2021.6554","volume":"19","author":"EFSA","year":"2021","unstructured":"EFSA. (2021). Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 3). EFSA Journal, 19(3), Article 6554. https:\/\/doi.org\/10.2903\/j.efsa.2021.6554","journal-title":"EFSA Journal"},{"issue":"S1","key":"759_CR37","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2019.e170709","volume":"17","author":"KC Elliott","year":"2019","unstructured":"Elliott, K. C. (2019). Managing value-laden judgements in regulatory science and risk assessment. EFSA Journal, 17(S1), Article e170709. https:\/\/doi.org\/10.2903\/j.efsa.2019.e170709","journal-title":"EFSA Journal"},{"key":"759_CR38","unstructured":"EMA. (2001). ICH Topic S 7 A on safety pharmacology studies for human pharmaceuticals. EMA. Retrieved 8 Jan 2024, from https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-s-7-safety-pharmacology-studies-human-pharmaceuticals-step-5_en.pdf"},{"key":"759_CR39","unstructured":"EMA. (2009). ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals. EMA. Retrieved 17 Dec 2022, from https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m3r2-non-clinical-safety-studies-conduct-human-clinical-trials-marketing-authorisation_en.pdf"},{"key":"759_CR40","unstructured":"EMA. (2016). Guideline on the scientific application and the practical arrangements necessary to implement Commission Regulation (EC) No 507\/2006 on the conditional marketing authorisation for medicinal products for human use falling within the scope of Regulation (EC) No 726\/2004. EMA\/CHMP\/509951\/2006, Rev.1. Retrieved 28 Jan 2025, from https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-scientific-application-and-practical-arrangements-necessary-implement-commission-regulation-ec-no-5072006-conditional-marketing-authorisation-medicinal-products-human-use-falling_en.pdf"},{"key":"759_CR41","unstructured":"EMA. (2019a). From laboratory to patient - the journey of a medicine assessed by EMA. EMA. Retrieved 14 Feb 2023, from https:\/\/www.ema.europa.eu\/en\/documents\/other\/laboratory-patient-journey-centrally-authorised-medicine_en.pdf"},{"key":"759_CR42","unstructured":"EMA. (2019b). Authorisation of medicines. EMA. Retrieved 12 Jan 2023, from https:\/\/www.ema.europa.eu\/en\/about-us\/what-we-do\/authorisation-medicines"},{"key":"759_CR43","unstructured":"EMA. (n.d.a). Indication. EMA. Retrieved 20 Mar 2023, from https:\/\/www.ema.europa.eu\/en\/glossary\/indication."},{"key":"759_CR44","unstructured":"EMA. (n.d.e). Metformin. EMA. Retrieved 31 Mar 2023, from https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/metformin-and-metformin-containing-medicines"},{"key":"759_CR45","unstructured":"EMA. (n.d.c). Clinical trials in human medicines. EMA. Retrieved 31 Mar 2023, from https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/clinical-trials-human-medicines"},{"key":"759_CR46","unstructured":"EMA. (n.d.b). Medicinal product. EMA. Retrieved 20 Mar 2023, from https:\/\/www.ema.europa.eu\/en\/glossary\/medicinal-product."},{"key":"759_CR47","unstructured":"EMA. (n.d.f). Rapamune. EMA. Retrieved 1 Apr 2023, from https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rapamune"},{"key":"759_CR48","unstructured":"EMA. (n.d.d). Efficacy. EMA. Retrieved 8 Jan 2024, from https:\/\/www.ema.europa.eu\/en\/glossary\/efficacy"},{"key":"759_CR28","unstructured":"European Commission. (2004). Regulation (EC) No 726\/2004 of the European Parliament and of the Council of 21 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. EUR-Lex. Retrieved 27 Dec 2022, from https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32004R0726"},{"key":"759_CR29","unstructured":"European Commission. (2008). Regulation (EC) No 353\/2008 of 18 April 2008 establishing implementing rules for applications for authorisation of health claims as provided for in Article 15 of Regulation (EC) No 1924\/2006 of the European Parliament and of the Council. EUR-Lex. Retrieved 27 Dec 2022, from https:\/\/eur-lex.europa.eu\/legal-content\/EN\/ALL\/?uri=CELEX%3A32008R0353"},{"key":"759_CR30","unstructured":"European Commission. (2025). Directive 2001\/83\/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. EUR-Lex. Retrieved 25 Jan 2025, from https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:02001L0083-20250101"},{"key":"759_CR49","unstructured":"European Parliament and Council. (2006). Regulation (EC) No 1924\/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. EUR-Lex. Retrieved 27 Dec 2022, from https:\/\/eur-lex.europa.eu\/legal-content\/en\/ALL\/?uri=CELEX%3A32006R1924"},{"key":"759_CR50","unstructured":"FDA. (2022). Letter from FDA CFSAN to Inner Mongolia Kingdomway Pharmaceutical Limited regarding NDI 1259- B-Nicotinamide Mononucleotide (NMN). Regulations.gov. Retrieved 25 Oct 2023, from https:\/\/www.regulations.gov\/document\/FDA-2022-S-0023-0051"},{"key":"759_CR51","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1007\/s11229-018-1840-6","volume":"196","author":"SC Fletcher","year":"2019","unstructured":"Fletcher, S. C., Landes, J., & Poellinger, R. (2019). Evidence amalgamation in the sciences: An introduction. Synthese, 196, 3163\u20133188. https:\/\/doi.org\/10.1007\/s11229-018-1840-6","journal-title":"Synthese"},{"issue":"11","key":"759_CR52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.006378","volume":"13","author":"K Foti","year":"2020","unstructured":"Foti, K., Foraker, R. E., Martyn-Nemeth, P., Anderson, C. A. M., Cook, N. R., Lichtenstein, A. H., de Ferranti, S. D., Young, D. R., Hivert, M.-F., Ross, R., Deedwania, P., Whitsel, L. P., & Appel, L. J. (2020). Evidence-based policy making for public health interventions in cardiovascular diseases: Formally assessing the feasibility of clinical trials. Circulation: Cardiovascular Quality and Outcomes, 13(11), Article e0063781. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.006378","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"key":"759_CR53","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.12.04091","volume":"12","author":"S Galvani-Townsend","year":"2022","unstructured":"Galvani-Townsend, S., Mart\u00ednez, I., & Pandey, A. (2022). Is life expectancy higher in countries and territories with publicly funded health care? Global analysis of health care access and the social determinants of health. Journal of Global Health, 12, Article 04091. https:\/\/doi.org\/10.7189\/jogh.12.04091","journal-title":"Journal of Global Health"},{"key":"759_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1192714","volume":"14","author":"L Gao","year":"2023","unstructured":"Gao, L., Liu, X., Luo, X., Lou, X., Li, P., Li, X., & Liu, X. (2023). Antiaging effects of dietary supplements and natural products. Frontiers in Pharmacology, 14, Article 1192714. https:\/\/doi.org\/10.3389\/fphar.2023.1192714","journal-title":"Frontiers in Pharmacology"},{"issue":"9","key":"759_CR55","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1038\/s44319-024-00226-2","volume":"25","author":"D Gems","year":"2024","unstructured":"Gems, D., Okholm, S., & Lemoine, M. (2024). Inflated expectations: The strange craze for translational research on aging. EMBO Reports, 25(9), 3748\u20133752. https:\/\/doi.org\/10.1038\/s44319-024-00226-2","journal-title":"EMBO Reports"},{"key":"759_CR56","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/acprof:oso\/9780199574131.003.0006","volume-title":"Causality in the sciences","author":"D Gillies","year":"2011","unstructured":"Gillies, D. (2011). The Russo\u2013Williamson thesis and the question of whether smoking causes heart disease. In P. M. Illari, F. Russo, & J. Williamson (Eds.), Causality in the sciences (pp. 110\u2013125). Oxford University Press."},{"key":"759_CR57","volume-title":"Deadly medicines and organised crime: How big pharma has corrupted healthcare","author":"PC G\u00f8tzsche","year":"2013","unstructured":"G\u00f8tzsche, P. C. (2013). Deadly medicines and organised crime: How big pharma has corrupted healthcare. Radcliffe Publishing."},{"key":"759_CR58","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139626866","volume-title":"Evidence matters. Science, proof, and truth in law","author":"S Haack","year":"2014","unstructured":"Haack, S. (2014). Evidence matters. Science, proof, and truth in law. Cambridge University Press."},{"key":"759_CR59","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1023\/b:hecf.0000047576.26633.67","volume":"16","author":"C Hackler","year":"2004","unstructured":"Hackler, C. (2004). Extending the life span: Mythic desires and modern dangers. HEC Forum, 16, 182\u2013196. https:\/\/doi.org\/10.1023\/b:hecf.0000047576.26633.67","journal-title":"HEC Forum"},{"issue":"6209","key":"759_CR60","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1126\/science.1254405","volume":"346","author":"S Harper","year":"2014","unstructured":"Harper, S. (2014). Economic and social implications of aging societies. Science, 346(6209), 587\u2013591. https:\/\/doi.org\/10.1126\/science.1254405","journal-title":"Science"},{"issue":"7253","key":"759_CR61","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","volume":"460","author":"DE Harrison","year":"2009","unstructured":"Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., Pahor, M., Javors, M. A., Fernandez, E., & Miller, R. A. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 460(7253), 392\u2013395. https:\/\/doi.org\/10.1038\/nature08221","journal-title":"Nature"},{"key":"759_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011666","volume":"6","author":"AJ Hatswell","year":"2016","unstructured":"Hatswell, A. J., Baio, G., Berlin, J. A., Irs, A., & Freemantle, N. (2016). Regulatory approval of pharmaceuticals without a randomised controlled study: Analysis of EMA and FDA approvals 1999-2014. British Medical Journal Open, 6, Article e011666. https:\/\/doi.org\/10.1136\/bmjopen-2016-011666","journal-title":"British Medical Journal Open"},{"issue":"9","key":"759_CR63","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/jn\/138.9.1591","volume":"138","author":"RP Heaney","year":"2008","unstructured":"Heaney, R. P. (2008). Nutrients, endpoints, and the problem of proof. The Journal of Nutrition, 138(9), 1591\u20131595. https:\/\/doi.org\/10.1093\/jn\/138.9.1591","journal-title":"The Journal of Nutrition"},{"issue":"5","key":"759_CR64","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/003591576505800503","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill, A. B. (1965). The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, 58(5), 295\u2013300.","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"759_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/9781444342673","volume-title":"The philosophy of evidence-based medicine","author":"J Howick","year":"2011","unstructured":"Howick, J. (2011a). The philosophy of evidence-based medicine. Wiley-Blackwell."},{"issue":"5","key":"759_CR66","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1086\/662561","volume":"78","author":"J Howick","year":"2011","unstructured":"Howick, J. (2011b). Exposing the vanities\u2014and a qualified defense\u2014of mechanistic reasoning in health care decision making. Philosophy of Science, 78(5), 926\u2013940. https:\/\/doi.org\/10.1086\/662561","journal-title":"Philosophy of Science"},{"issue":"2","key":"759_CR67","doi-asserted-by":"publisher","first-page":"480","DOI":"10.14336\/AD.2020.0702","volume":"12","author":"D Hu","year":"2021","unstructured":"Hu, D., Xie, F., Xiao, Y., Lu, C., Zhong, J., Huang, D., Chen, J., Wei, J., Jian, Y., & Zhong, T. (2021). Metformin: A potential candidate for targeting aging mechanisms. Aging and Disease, 12(2), 480\u2013493. https:\/\/doi.org\/10.14336\/AD.2020.0702","journal-title":"Aging and Disease"},{"key":"759_CR68","unstructured":"ICH. (1998). ICH harmonised tripartite guideline: Statistical principles for clinical trials E9. ICH Harmonisation for better health. Retrieved 15 Feb 2025, from https:\/\/database.ich.org\/sites\/default\/files\/E9_Guideline.pdf"},{"issue":"2","key":"759_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/02698595.2011.574856","volume":"25","author":"PM Illari","year":"2011","unstructured":"Illari, P. M. (2011). Mechanistic evidence: Disambiguating the Russo\u2013Williamson thesis. International Studies in the Philosophy of Science, 25(2), 139\u2013157. https:\/\/doi.org\/10.1080\/02698595.2011.574856","journal-title":"International Studies in the Philosophy of Science"},{"key":"759_CR70","volume-title":"The fifth branch. Science advisers as policymakers","author":"S Jasanoff","year":"1990","unstructured":"Jasanoff, S. (1990). The fifth branch. Science advisers as policymakers. Harvard University Press."},{"issue":"1","key":"759_CR71","first-page":"167","volume":"39","author":"S Jasanoff","year":"2010","unstructured":"Jasanoff, S., Kurihara, C., & Saio, T. (2010). What is regulatory science? Concept and history in United States and in Japan. Clinical Evaluation, 39(1), 167\u2013180.","journal-title":"Clinical Evaluation"},{"issue":"4","key":"759_CR72","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11357-018-0036-9","volume":"40","author":"M Kaeberlein","year":"2018","unstructured":"Kaeberlein, M. (2018). How healthy is the healthspan concept? GeroScience, 40(4), 361\u2013364. https:\/\/doi.org\/10.1007\/s11357-018-0036-9","journal-title":"GeroScience"},{"issue":"5","key":"759_CR73","first-page":"345","volume":"53","author":"PJ Karanicolas","year":"2010","unstructured":"Karanicolas, P. J., Farrokhyar, F., & Bhandari, M. (2010). Blinding: Who, what, when, why, how? Canadian Journal of Surgery, 53(5), 345\u2013348.","journal-title":"Canadian Journal of Surgery"},{"key":"759_CR74","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/emj.20.2.164","volume":"20","author":"J Kendall","year":"2003","unstructured":"Kendall, J. (2003). Designing a research project: Randomised controlled trials and their principles. Emergency Medicine Journal, 20, 164\u2013168. https:\/\/doi.org\/10.1136\/emj.20.2.164","journal-title":"Emergency Medicine Journal"},{"issue":"1","key":"759_CR75","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36(1), 559\u2013574. https:\/\/doi.org\/10.1146\/annurev-publhealth-031914-122957","journal-title":"Annual Review of Public Health"},{"issue":"1","key":"759_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020). Benefits of metformin in attenuating the hallmarks of ageing. Cell Metabolism, 32(1), 15\u201330. https:\/\/doi.org\/10.1016\/j.cmet.2020.04.001","journal-title":"Cell Metabolism"},{"issue":"5","key":"759_CR77","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/jmp\/jhp034","volume":"34","author":"A La Caze","year":"2009","unstructured":"La Caze, A. (2009). Evidence-based medicine must be. Journal of Medicine and Philosophy, 34(5), 509\u2013527. https:\/\/doi.org\/10.1093\/jmp\/jhp034","journal-title":"Journal of Medicine and Philosophy"},{"issue":"5","key":"759_CR78","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025924","volume":"6","author":"DW Lamming","year":"2016","unstructured":"Lamming, D. W. (2016). Inhibition of the mechanistic target of rapamycin (mTOR)\u2014Rapamycin and beyond. Cold Spring Harbor Perspectives in Medicine, 6(5), Article a025924. https:\/\/doi.org\/10.1101\/cshperspect.a025924","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"759_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s10539-020-09765-z","volume":"35","author":"M Lemoine","year":"2020","unstructured":"Lemoine, M. (2020). Defining aging. Biology & Philosophy, 35, Article 46. https:\/\/doi.org\/10.1007\/s10539-020-09765-z","journal-title":"Biology & Philosophy"},{"issue":"4","key":"759_CR80","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/acel.12338","volume":"14","author":"VD Longo","year":"2015","unstructured":"Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown-Borg, H. M., Caruso, C., Curiel, T. J., de Cabo, R., Franceschi, C., Gems, D., Ingram, D. K., Johnson, T. E., Kennedy, B. K., Kenyon, C., Klein, S., Kopchick, J. J., Lepperdinger, G., Madeo, F., Mirisola, M., & Fontana, L. (2015). Interventions to slow aging in humans: Are we ready? Aging Cell, 14(4), 497\u2013510. https:\/\/doi.org\/10.1111\/acel.12338","journal-title":"Aging Cell"},{"issue":"2","key":"759_CR81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/09637486.2021.1948508","volume":"73","author":"R L\u00f3pez-Mas","year":"2022","unstructured":"L\u00f3pez-Mas, R., & Luj\u00e1n, J. L. (2022). The essentiality of nutrients: A challenge to methodological monism in the scientific substantiation of health claims. International Journal of Food Sciences and Nutrition, 73(2), 149\u2013153. https:\/\/doi.org\/10.1080\/09637486.2021.1948508","journal-title":"International Journal of Food Sciences and Nutrition"},{"issue":"3","key":"759_CR82","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/scipol\/scad077","volume":"51","author":"R L\u00f3pez-Mas","year":"2024","unstructured":"L\u00f3pez-Mas, R., & Luj\u00e1n, J. L. (2024). Comparing regulatory options: The role of epistemic policies and pragmatic consequences. Science and Public Policy, 51(3), 352\u2013359. https:\/\/doi.org\/10.1093\/scipol\/scad077","journal-title":"Science and Public Policy"},{"issue":"6","key":"759_CR83","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2013.05.039","journal-title":"Cell"},{"issue":"2","key":"759_CR84","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023). Hallmarks of aging: An expanding universe. Cell, 186(2), 243\u2013278. https:\/\/doi.org\/10.1016\/j.cell.2022.11.001","journal-title":"Cell"},{"key":"759_CR85","doi-asserted-by":"publisher","unstructured":"Lu, A. T., Binder, A. M., Zhang, J., Yan, Q., Reiner, A. P., Cox, S. R., Corley, J., Harris, S. E., Kuo, P. L., Moore, A. Z., Bandinelli, S., Stewat , J. D., Wang, C., Hamlat, E. J., Epel, E. S., Schwartz, J. D., Whitsel, E. A., Correa, A., Ferrari, L., Horvath, S. (2022). DNA Methylation GrimAge version 2. Aging, 14(23), 9484\u20139549. https:\/\/doi.org\/10.18632\/aging.204434","DOI":"10.18632\/aging.204434"},{"key":"759_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-319-71958-0_5","volume-title":"Spanish philosophy of technology. Philosophy of engineering and technology","author":"JL Luj\u00e1n","year":"2018","unstructured":"Luj\u00e1n, J. L., & Todt, O. (2018a). Regulatory science: Between technology and society. In B. Laspra & J. A. L\u00f3pez Cerezo (Eds.), Spanish philosophy of technology. Philosophy of engineering and technology (pp. 59\u201372). Springer."},{"issue":"2","key":"759_CR87","doi-asserted-by":"publisher","first-page":"194","DOI":"10.15252\/embr.201744795","volume":"19","author":"JL Luj\u00e1n","year":"2018","unstructured":"Luj\u00e1n, J. L., & Todt, O. (2018b). The dilemmas of science for policy: Scientific evidence and the consequences of regulatory options in risk and benefit assessment. EMBO Reports, 19(2), 194\u2013196. https:\/\/doi.org\/10.15252\/embr.201744795","journal-title":"EMBO Reports"},{"issue":"26","key":"759_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13194-020-00340-7","volume":"11","author":"JL Luj\u00e1n","year":"2021","unstructured":"Luj\u00e1n, J. L., & Todt, O. (2021). Evidence-based methodology: A naturalistic analysis of epistemic policies in regulatory science. European Journal for Philosophy of Science, 11(26), 1\u201319. https:\/\/doi.org\/10.1007\/s13194-020-00340-7","journal-title":"European Journal for Philosophy of Science"},{"issue":"1","key":"759_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/392759","volume":"67","author":"P Machamer","year":"2000","unstructured":"Machamer, P., Darden, L., & Craver, C. F. (2000). Thinking about mechanisms. Philosophy of Science, 67(1), 1\u201325. https:\/\/doi.org\/10.1086\/392759","journal-title":"Philosophy of Science"},{"key":"759_CR90","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00148-018-0717-9","volume":"32","author":"M Mainul Hoque","year":"2019","unstructured":"Mainul Hoque, M., King, E. M., & Montenegro, C. E. (2019). Revisiting the relationship between longevity and lifetime education: Global evidence from 919 surveys. Journal of Population Economics, 32, 551\u2013589. https:\/\/doi.org\/10.1007\/s00148-018-0717-9","journal-title":"Journal of Population Economics"},{"key":"759_CR91","unstructured":"Margulis, M. V., Pladevall, M., Riera-Guardia, N., Seeger, J., Patorno, E., & Varas-Lorenzo, C. (2016). Comment on: Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. PubPeer. Retrieved 14 Feb 2025, from https:\/\/pubpeer.com\/publications\/4E29C6C9E32D2C24662AED78A59AC5."},{"issue":"4","key":"759_CR92","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/meta.12642","volume":"54","author":"G Mar\u00edn Penella","year":"2023","unstructured":"Mar\u00edn Penella, G. (2023). A socio-epistemological program for the philosophy of regulatory science. Metaphilosophy, 54(4), 480\u2013492. https:\/\/doi.org\/10.1111\/meta.12642","journal-title":"Metaphilosophy"},{"issue":"5","key":"759_CR93","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/bioe.13265","volume":"38","author":"G Mar\u00edn Penella","year":"2024","unstructured":"Mar\u00edn Penella, G. (2024). Should the European Medicines Agency consider ageing a disease? Bioethics, 38(5), 431\u2013437. https:\/\/doi.org\/10.1111\/bioe.13265","journal-title":"Bioethics"},{"key":"759_CR94","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1038\/ncomms3192","volume":"4","author":"M Mart\u00edn-Montalvo","year":"2013","unstructured":"Mart\u00edn-Montalvo, M., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M. J., Schwab, N., Pollak, M., Zhang, Y., Yu, Y., Becker, K. G., Bohr, V. A., Ingram, D. K., Sinclair, D. A., Wolf, N. S., & de Cabo, R. (2013). Metformin improves healthspan and lifespan in mice. Nature Communications, 4, 2192. https:\/\/doi.org\/10.1038\/ncomms3192","journal-title":"Nature Communications"},{"key":"759_CR95","unstructured":"McConway, K. (2014). Expert reaction to study looking at type 2 diabetes, metformin and lifespan. Science Media Centre. Retrieved 14 Feb 2025, from\u00a0 http:\/\/www.sciencemediacentre.org\/expert-reaction-to-study-looking-at-type-2-diabetes-metformin-and-lifespan\/"},{"issue":"3","key":"759_CR96","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/acel.12194","volume":"13","author":"RA Miller","year":"2013","unstructured":"Miller, R. A., Harrison, D. E., Astle, C. M., Fernandez, E., Flurkey, K., Han, M., Javors, M. A., Li, X., Nadon, N. L., Nelson, J. F., Pletcher, S., Salmon, A. B., Sharp, Z. D., Van Roekel, S., Winkleman, L., & Strong, R. (2013). Rapamycin\u2013mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell, 13(3), 468\u2013477. https:\/\/doi.org\/10.1111\/acel.12194","journal-title":"Aging Cell"},{"issue":"2","key":"759_CR97","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1017\/S0007114510003296","volume":"105","author":"HL Mitchell","year":"2011","unstructured":"Mitchell, H. L., Aggett, P. J., Richardson, D. P., & Stowell, J. D. (2011). Food & health forum meeting: Evidence-based nutrition. British Journal of Nutrition, 105(2), 322\u2013328. https:\/\/doi.org\/10.1017\/S0007114510003296","journal-title":"British Journal of Nutrition"},{"key":"759_CR98","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/tsq.12079","volume":"56","author":"T Moreira","year":"2015","unstructured":"Moreira, T. (2015). Unsettling standards: The biological age controversy. The Sociological Quarterly, 56, 18\u201339. https:\/\/doi.org\/10.1111\/tsq.12079","journal-title":"The Sociological Quarterly"},{"key":"759_CR99","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd.2018.134","volume":"17","author":"A Mullard","year":"2018","unstructured":"Mullard, A. (2018). Anti-ageing pipeline starts to mature. Nature Reviews Drug Discovery, 17, 609\u2013612. https:\/\/doi.org\/10.1038\/nrd.2018.134","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"759_CR100","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11357-008-9048-1","volume":"30","author":"NL Nadon","year":"2008","unstructured":"Nadon, N. L., Strong, R., Miller, R. A., & Harrison, D. E. (2008). Design of aging intervention studies: The NIA interventions testing program. Age, 30(4), 187\u2013199. https:\/\/doi.org\/10.1007\/s11357-008-9048-1","journal-title":"Age"},{"issue":"1","key":"759_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/advances\/nmy113","volume":"10","author":"EP Neale","year":"2019","unstructured":"Neale, E. P., & Tapsell, L. C. (2019). Perspective: The evidence-based framework in nutrition and dietetics: Implementation, challenges, and future directions. Advances in Nutrition, 10(1), 1\u20138. https:\/\/doi.org\/10.1093\/advances\/nmy113","journal-title":"Advances in Nutrition"},{"key":"759_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.820215","volume":"3","author":"JL Nielsen","year":"2022","unstructured":"Nielsen, J. L., Bakula, D., & Scheibye-Knudsen, M. (2022). Clinical trials targeting aging. Frontiers in Aging, 3, Article 820215. https:\/\/doi.org\/10.3389\/fragi.2022.820215","journal-title":"Frontiers in Aging"},{"key":"759_CR103","unstructured":"NIH. (n.d.). Overall survival. Retrieved 9 Feb 2024, from https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/overall-survival"},{"key":"759_CR104","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/978-3-030-29179-2_15","volume-title":"Uncertainty in pharmacology: Epistemology, methods, and decisions","author":"B Osimani","year":"2020","unstructured":"Osimani, B. (2020). Epistemic gains and epistemic games: Reliability and higher order evidence in medicine and pharmacology. In A. La Caze & B. Osimani (Eds.), Uncertainty in pharmacology: Epistemology, methods, and decisions (pp. 345\u2013372). Springer."},{"key":"759_CR105","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-94610-8","volume-title":"Evaluating evidence of mechanisms in medicine: Principles and procedures","author":"VP Parkkinen","year":"2018","unstructured":"Parkkinen, V. P., Wallmann, C., Wilde, M., Clarke, B., Illari, P., Kelly, M. P., Norell, C., Russo, F., Shaw, B., & Williamson, J. (2018). Evaluating evidence of mechanisms in medicine: Principles and procedures. Springer."},{"key":"759_CR106","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.shpsa.2023.11.006","volume":"103","author":"S P\u00e9rez-Gonz\u00e1lez","year":"2024","unstructured":"P\u00e9rez-Gonz\u00e1lez, S. (2024). Evidence of mechanisms in evidence-based policy. Studies in History and Philosophy of Science, 103, 95\u2013104. https:\/\/doi.org\/10.1016\/j.shpsa.2023.11.006","journal-title":"Studies in History and Philosophy of Science"},{"issue":"10","key":"759_CR107","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/jme.2006.017822","volume":"33","author":"MAM Pijnenburg","year":"2007","unstructured":"Pijnenburg, M. A. M., & Leget, C. (2007). Who wants to live forever? Three arguments against extending the human lifespan. Journal of Medical Ethics, 33(10), 585\u2013587. https:\/\/doi.org\/10.1136\/jme.2006.017822","journal-title":"Journal of Medical Ethics"},{"issue":"1","key":"759_CR108","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/0048393108328150","volume":"39","author":"J Reiss","year":"2009","unstructured":"Reiss, J. (2009). Causation in the social sciences: Evidence, inference, and purpose. Philosophy of the Social Sciences, 39(1), 20\u201340. https:\/\/doi.org\/10.1177\/0048393108328150","journal-title":"Philosophy of the Social Sciences"},{"issue":"1","key":"759_CR109","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1017\/S002966511100317X","volume":"71","author":"DP Richardson","year":"2012","unstructured":"Richardson, D. P. (2012). Preparing dossiers: Strength of the evidence and problems of proof. Proceedings of the Nutrition Society, 71(1), 127\u2013140. https:\/\/doi.org\/10.1017\/S002966511100317X","journal-title":"Proceedings of the Nutrition Society"},{"issue":"5","key":"759_CR110","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/jep.13859","volume":"29","author":"E Rocca","year":"2023","unstructured":"Rocca, E., & P\u00e9rez-Gonz\u00e1lez, S. (2023). Evaluating the relevance of epidemiological studies for the single patient: How can evidence of mechanisms help? Journal of Evaluation in Clinical Practice, 29(5), 822\u2013824. https:\/\/doi.org\/10.1111\/jep.13859","journal-title":"Journal of Evaluation in Clinical Practice"},{"key":"759_CR111","unstructured":"Roser, M., Ortiz-Ospina, E., & Ritchie, H. (2013). Life expectancy. Our World in Data. Retrieved 24 Oct 2023, from https:\/\/ourworldindata.org\/life-expectancy"},{"issue":"1","key":"759_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/287231","volume":"20","author":"R Rudner","year":"1953","unstructured":"Rudner, R. (1953). The scientist qua scientist makes value judgments. Philosophy of Science, 20(1), 1\u20136.","journal-title":"Philosophy of Science"},{"issue":"2","key":"759_CR113","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/02698590701498084","volume":"21","author":"F Russo","year":"2007","unstructured":"Russo, F., & Williamson, J. (2007). Interpreting causality in the health sciences. International Studies in the Philosophy of Science, 21(2), 157\u2013170. https:\/\/doi.org\/10.1080\/02698590701498084","journal-title":"International Studies in the Philosophy of Science"},{"issue":"4","key":"759_CR114","first-page":"563","volume":"33","author":"F Russo","year":"2011","unstructured":"Russo, F., & Williamson, J. (2011). Epistemic causality and evidence-based medicine. History and Philosophy of the Life Sciences, 33(4), 563\u2013581.","journal-title":"History and Philosophy of the Life Sciences"},{"issue":"7023","key":"759_CR115","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","volume":"312","author":"DL Sackett","year":"1996","unstructured":"Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence based medicine: What it is and what it isn\u2019t. BMJ, 312(7023), 71\u201372. https:\/\/doi.org\/10.1136\/bmj.312.7023.71","journal-title":"BMJ"},{"issue":"4","key":"759_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02691728.2021.2004467","volume":"36","author":"N Sanz Merino","year":"2022","unstructured":"Sanz Merino, N. (2022). Policy styles and epistemic policies in the regulation of health claims: A comparison of Europe, the United States, and Japan. Social Epistemology, 36(4), 1\u201317. https:\/\/doi.org\/10.1080\/02691728.2021.2004467","journal-title":"Social Epistemology"},{"key":"759_CR117","first-page":"99","volume-title":"Acceptable evidence: Science and values in risk management","author":"EK Silbergeld","year":"1991","unstructured":"Silbergeld, E. K. (1991). Risk assessment and risk management: An uneasy divorce. In D. G. Mayo & R. D. Hollander (Eds.), Acceptable evidence: Science and values in risk management (pp. 99\u2013114). Oxford University Press."},{"key":"759_CR118","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jmst.2022.04.018","volume":"128","author":"X Song","year":"2022","unstructured":"Song, X., Song, X., Tang, Z., Liu, W., Chen, K., Liang, J., Yuan, B., Lin, H., Zhu, X., Fan, Y., Shi, X., Zhao, P., Yang, L., Zhang, K., Mikos, A. G., & Zhang, X. (2022). Biomaterials and regulatory science. Journal of Materials Science & Technology, 128, 221\u2013227. https:\/\/doi.org\/10.1016\/j.jmst.2022.04.018","journal-title":"Journal of Materials Science & Technology"},{"issue":"1","key":"759_CR119","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2147\/NDT.S101938","volume":"12","author":"PM Spieth","year":"2016","unstructured":"Spieth, P. M., Kubasch, A. S., Penzlin, A. I., Illigens, B. M., Barlinn, K., & Siepmann, T. (2016). Randomized controlled trials\u2014a matter of design. Neuropsychiatric Disease and Treatment, 12(1), 1341\u20131349. https:\/\/doi.org\/10.2147\/NDT.S101938","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"2","key":"759_CR120","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s11245-013-9189-4","volume":"33","author":"J Stegenga","year":"2014","unstructured":"Stegenga, J. (2014). Down with the hierarchies. Topoi, 33(2), 244\u2013247. https:\/\/doi.org\/10.1007\/s11245-013-9189-4","journal-title":"Topoi"},{"issue":"4","key":"759_CR121","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/sti.76.4.244","volume":"76","author":"JM Stephenson","year":"2000","unstructured":"Stephenson, J. M., & Babiker, A. (2000). Overview of study design in clinical epidemiology. Sexually Transmitted Infections, 76(4), 244\u2013247. https:\/\/doi.org\/10.1136\/sti.76.4.244","journal-title":"Sexually Transmitted Infections"},{"key":"759_CR122","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/978-3-030-29179-2_18","volume-title":"Uncertainty in pharmacology: Epistemology, methods, and decisions","author":"D Teira","year":"2020","unstructured":"Teira, D. (2020). On the normative foundations of pharmaceutical regulation. In A. La Caze & B. Osimani (Eds.), Uncertainty in pharmacology: Epistemology, methods, and decisions (pp. 417\u2013437). Springer."},{"issue":"4","key":"759_CR123","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/13669877.2015.1100661","volume":"20","author":"O Todt","year":"2017","unstructured":"Todt, O., & Luj\u00e1n, J. L. (2017). The role of epistemic policies in regulatory science: Scientific substantiation of health claims in the European Union. Journal of Risk Research, 20(4), 349\u2013362. https:\/\/doi.org\/10.1080\/13669877.2015.1100661","journal-title":"Journal of Risk Research"},{"issue":"12","key":"759_CR124","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1080\/13669877.2021.1873825","volume":"24","author":"O Todt","year":"2021","unstructured":"Todt, O., & Luj\u00e1n, J. L. (2021). Constructing consumers: Regulatory and methodological consequences of defining consumer preferences in European health claim regulation. Journal of Risk Research, 24(12), 1532\u20131543. https:\/\/doi.org\/10.1080\/13669877.2021.1873825","journal-title":"Journal of Risk Research"},{"issue":"S1","key":"759_CR125","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/09637486.2012.665439","volume":"63","author":"F Visioli","year":"2012","unstructured":"Visioli, F. (2012). Can experimental pharmacology be always applied to human nutrition? International Journal of Food Sciences and Nutrition, 63(S1), 10\u201313. https:\/\/doi.org\/10.3109\/09637486.2012.665439","journal-title":"International Journal of Food Sciences and Nutrition"},{"issue":"3","key":"759_CR126","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.toxlet.2004.05.010","volume":"152","author":"B Wandall","year":"2004","unstructured":"Wandall, B. (2004). Values in science and risk assessment. Toxicology Letters, 152(3), 265\u2013272. https:\/\/doi.org\/10.1016\/j.toxlet.2004.05.010","journal-title":"Toxicology Letters"},{"key":"759_CR127","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-981-19-7443-4_15","volume-title":"Emerging anti-aging strategies","author":"CS Wareham","year":"2023","unstructured":"Wareham, C. S., & Garc\u00eda-Barranquero, P. (2023). A vaccine for the pandemic of aging? Conceptual and ethical issues. In S. I. Rizvi (Ed.), Emerging anti-aging strategies (pp. 269\u2013285). Springer."},{"key":"759_CR128","unstructured":"WHO. (2022). WHO clinical consortium on healthy ageing 2022: report of consortium meeting, 5\u20136 December 2022. World Health Organization. Retrieved 25 Jan 2025, from https:\/\/iris.who.int\/bitstream\/handle\/10665\/372136\/9789240076822-eng.pdf?sequence=1"},{"issue":"1","key":"759_CR129","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/02698595.2019.1630927","volume":"32","author":"J Williamson","year":"2019","unstructured":"Williamson, J. (2019). Establishing causal claims in medicine. International Studies in the Philosophy of Science, 32(1), 33\u201361. https:\/\/doi.org\/10.1080\/02698595.2019.1630927","journal-title":"International Studies in the Philosophy of Science"},{"issue":"Suppl. 2","key":"759_CR130","doi-asserted-by":"publisher","first-page":"S2505","DOI":"10.1007\/s11229-018-1889-2","volume":"198","author":"J Williamson","year":"2021","unstructured":"Williamson, J. (2021). Establishing the teratogenicity of Zika and evaluating causal criteria. Synthese, 198(Suppl. 2), S2505\u2013S2518. https:\/\/doi.org\/10.1007\/s11229-018-1889-2","journal-title":"Synthese"},{"issue":"S3","key":"759_CR131","doi-asserted-by":"publisher","first-page":"S316","DOI":"10.1007\/s11245-020-09703-4","volume":"69","author":"J Worrall","year":"2002","unstructured":"Worrall, J. (2002). What evidence in evidence-based medicine? Philosophy of Science, 69(S3), S316\u2013S330. https:\/\/doi.org\/10.1007\/s11245-020-09703-4","journal-title":"Philosophy of Science"},{"issue":"3","key":"759_CR132","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/bjps\/axm024","volume":"58","author":"J Worrall","year":"2007","unstructured":"Worrall, J. (2007). Why there\u2019s no cause to randomize. The British Journal for the Philosophy of Science, 58(3), 451\u2013488. https:\/\/doi.org\/10.1093\/bjps\/axm024","journal-title":"The British Journal for the Philosophy of Science"},{"key":"759_CR133","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/978-3-030-22009-9_799","volume-title":"Encyclopedia of gerontology and population aging","author":"RD Young","year":"2021","unstructured":"Young, R. D. (2021). Maximum lifespan. In D. Gu & M. E. Dupre (Eds.), Encyclopedia of gerontology and population aging (pp. 3073\u20133092). Springer."}],"container-title":["History and Philosophy of the Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40656-026-00759-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40656-026-00759-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40656-026-00759-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:02:27Z","timestamp":1790334147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40656-026-00759-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1007\/s40656-026-00759-w","relation":{},"ISSN":["0391-9714","1742-6316"],"issn-type":[{"value":"0391-9714","type":"print"},{"value":"1742-6316","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}